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A 69-year-old man with benign prostate hyperplasia (BPH)
was admitted for the workup of renal failure. Besides his
urological disorder, the patient suffered from Waldenstro¨m’s
macroglobulinemia, which was diagnosed in 1997.
Laboratory results on admission are displayed in Table 1.
Despite markedly elevated serum creatinine and slight
anemia, the patient’s subjective health and physical examina-
tion were unremarkable. In particular, he was afebrile and his
blood pressure was 133/76 mm Hg. Furthermore, the patient
denied taking nephrotoxic medications. He complained of
diarrhea 1 week before consultation. The patient was on
tamsulosin 0.4 mg once daily. Ultrasonographic evaluation of
the kidneys revealed hydronephrosis with normal cortical
thickness of both kidneys, likely caused by BPH. On the basis
of ultrasound results, ureteral double pigtail stents were
placed in both kidneys and rehydration therapy was initiated
thereafter. Despite this therapeutic intervention, creatinine
remained elevated (range from 2.8 to 5.1 mg per dl). A renal
biopsy that was performed in view of the patient’s atypical
course showed arteriolar and arterial sclerosis (benign
nephrosclerosis) with obsolescence of 5 out of 15 glomeruli
(10 glomeruli were normal), as well as focal tubular atrophy
(10–15%) and interstitial fibrosis. Immunohistology (IgA,
IgG, IgM, C1q, C3c, fibrin/fibrinogen, and albumin) was
completely negative, except for nonspecific arteriolar deposits
of C3c (arteriolohyalinosis).
What is the differential diagnosis for renal failure in this patient?
How can the diagnosis be confirmed?
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Table 1 | Patient laboratory results with corresponding reference intervals
Reference interval
Leukocytes ( 109/l) 6.4 4–10
Hemoglobin (g/dl) 11.3 13–17
Erythrocyte volume (fl) 83 83–97
Platelets ( 109/l) 396 150–440
Sodium (mmol/l) 137 135–145
Potassium (mmol/l) 4.1 3.5–4.8
Phosphate (mmol/l) 1.6 0.8–1.5
Creatinine (mg/dl) 4.6 0.1–1.3
Blood urea nitrogen (mg/dl) 38 o45
Parathyroid hormone (pmol/l) 2.7 1.3–7.6
Uric acid (mg/dl) 1.1 o7
Protein total (g/l) 98.4 60–80
Immunoglobulin M (g/l) 36.1 0.4–2.3
Immunoglobulin G (g/l) 0.5 7.0–16.0
C-reactive protein (mg/dl) 8.6 o5
ANA (titer) neg. p1:80
ANCA (titer) neg. o1:10
Anti-GBM (titer) neg. o1:10
Anti-dsDNA (IU/ml) 40 p40
Urine protein (g per 24 h) 1.1 o0.3
Urine red cells neg. neg.
Urine leukocytes neg. neg.
Urine nitrites neg. neg.
Abbreviations: ANA, antinuclear antibody; ANCA, antineutrophil cytoplasmic antibody; anti-dsDNA, double-stranded-DNA antibody;
anti-GBM, anti-glomerular basement membrane antibody; neg., negative.
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The Diagnosis | Pseudohypercreatininemia associated
with paraproteinemia
As the patient’s symptoms and renal biopsy were discordant
with the degree of creatinine elevation, the diagnosis of
pseudohypercreatininemia was entertained. A different para-
meter for the estimation of kidney function, cystatin C (CysC),
was only slightly elevated at 1.4 mg per dl (0.7–1.2 mg per dl),
reflecting an estimated glomerular filtration rate of 60 ml/min
per 1.73 m2, thereby suggesting that enzymatic creatinine
measurements obtained so far were inaccurate (Table 2).
Therefore, creatinine levels were determined using the non-
enzymatic Jaffe´ method, yielding a creatinine concentration of
1.0 mg per dl (consistent with the only slightly elevated CysC
values). The latter indicated only a mild impairment of kidney
function appropriate for the patient’s age and correlated well
with other laboratory results and kidney biopsy.
Paraproteins (in this case, the monoclonal IgM associated
with Waldenstro¨m’s disease) can lead to falsely elevated
plasma creatinine concentration from interference of routine
enzymatic laboratory test (creatininedeaminase method:
conversion of creatinine to ammonium and N-methylhydan-
toin, and subsequent detection of ammoniac using a
glutamate dehydrogenase-dependent method). Conversely,
the Jaffe´ method, in which creatinine reacts nonenzymatically
with picric acid, forming a colored complex, yielded correct
values for plasma creatinine in this case.
IgM interference in creatinine determination has been
rarely reported when using enzymatic methods.1,2 In
pseudohypercreatininemia, monoclonal IgMs may form a
complex with reagents, thereby interfering with measurement
of the enzymatic reaction.1 Other mechanisms explaining the
interference have been proposed. Increased turbidity due to
high IgM concentration is the most frequently proposed
mechanism, which can lead to false-low or false-high results.3
A less frequent mechanism is the binding of monoclonal
immunoglobulin to either the analyte or one of the test’s
components. This may inactivate test components, for
example, an enzyme, usually resulting in false-low results.3
Interference may also be caused by higher viscosity due to a
very high IgM concentration or gel formation in refrigerated
samples, as in the case of cryoglobulinemia.
Monoclonal paraproteins have been shown to artificially
influence different methodologies of automated assays,
including nephelometry, turbidometry, and immunological
assays.3,4 To date, IgMs have been reported to interfere with
determination of C-reactive protein, bilirubin, uric acid,
high-density lipoprotein cholesterol, and, most frequently,
phosphate.3–5 Interestingly, these problems affect only a
single or few parameters in individual cases and occur only in
some, but not all, patients with elevated IgMs. This
‘selectivity’ may be explained by IgM subtype-specific assay
interference.
In summary, pseudohypercreatininemia secondary to a
monoclonal IgM should be considered in patients with an
isolated creatinine elevation, particularly when associated
with normal urea or elevated total protein. We propose that
in these cases, IgM should be quantitated to test for
Waldenstro¨m’s macroglobulinemia, if not known already in
the patient. In addition and importantly, an alternative
method for estimating renal function (CysC, Jaffe´ method)
needs to be used, to correctly analyze renal function and to
avert unnecessary tests or procedures.
DISCLOSURE
All the authors declared no competing interests.
REFERENCES
1. Hummel KM, von Ahsen N, Ku¨hn RB et al. Pseudohypercreatininemia due
to positive interference in enzymatic creatinine measurements caused by
monoclonal IgM in patients with Waldenstro¨m’s macroglobulinemia.
Nephron 2000; 86: 188–189.
2. Storsley L, Fine A, Krahn J. IgM monoclonal protein presenting as
pseudohypercreatininaemia. Nephrol Dial Transplant 2006; 21:
3337–3338.
3. Bakker AJ, Mu¨cke M. Gammopathy interference in clinical chemistry
assays: mechanisms, detection and prevention. Clin Chem Lab Med 2007;
45: 1240–1243.
4. Yang Y, Howanitz PJ, Howanitz JH et al. Paraproteins are a common cause
of interferences with automated chemistry methods. Arch Pathol Lab Med
2008; 132: 217–223.
5. Berth M, Delanghe J. Protein precipitation as a possible important pitfall
in the clinical chemistry analysis of blood samples containing monoclonal
immunoglobulins: 2 case reports and a review of the literature. Acta Clin
Belg 2004; 59: 263–273.
Table 2 | Creatinine determined with Jaffe´ method and cystatin C
values
Parameters of renal function Reference interval
Creatinine (Jaffe´) (mg/dl) 1.0 0.1–1.3
Cystatin C (mg/dl) 1.4 0.7–1.2
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